Cambridge Investment Research Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,875
| Closed | -$13K | – | 3333 |
|
|
2023
Q1 | $13K | Buy |
+10,875
| New | +$24.2K | ﹤0.01% | 3127 |
|
|
2022
Q3 | – | Sell |
-46,200
| Closed | -$105K | – | 3183 |
|
|
2022
Q2 | $105K | Buy |
46,200
+2,100
| +5% | +$7.82K | ﹤0.01% | 2860 |
|
|
2022
Q1 | $297K | Buy |
44,100
+8,938
| +25% | +$76.4K | ﹤0.01% | 2565 |
|
|
2021
Q4 | $318K | Sell |
35,162
-3,037
| -8% | -$28.2K | ﹤0.01% | 2481 |
|
|
2021
Q3 | $386K | Sell |
38,199
-124,973
| -77% | -$1.37M | ﹤0.01% | 2248 |
|
|
2021
Q2 | $2.1M | Sell |
163,172
-18,657
| -10% | -$256K | 0.01% | 1087 |
|
|
2021
Q1 | $2.57M | Buy |
181,829
+44,380
| +32% | +$611K | 0.01% | 887 |
|
|
2020
Q4 | $1.47M | Buy |
137,449
+55,375
| +67% | +$503K | 0.01% | 1091 |
|
|
2020
Q3 | $627K | Buy |
82,074
+10,658
| +15% | +$78.4K | ﹤0.01% | 1458 |
|
|
2020
Q2 | $433K | Buy |
71,416
+8,375
| +13% | +$41.3K | ﹤0.01% | 1641 |
|
|
2020
Q1 | $222K | Buy |
63,041
+1,825
| +3% | +$15.5K | ﹤0.01% | 1867 |
|
|
2019
Q4 | $646K | Buy |
61,216
+8,500
| +16% | +$75.5K | 0.01% | 1416 |
|
|
2019
Q3 | $590K | Buy |
52,716
+4,550
| +9% | +$53.9K | 0.01% | 1391 |
|
|
2019
Q2 | $441K | Buy |
48,166
+14,150
| +42% | +$148K | ﹤0.01% | 1511 |
|
|
2019
Q1 | $377K | Buy |
+34,016
| New | +$238K | ﹤0.01% | 1664 |
|
|
2017
Q1 | – | Sell |
-9,637
| Closed | -$242K | – | 1822 |
|
|
2016
Q4 | $242K | Buy |
9,637
+487
| +5% | +$11.5K | ﹤0.01% | 1394 |
|
|
2016
Q3 | $227K | Buy |
+9,150
| New | +$243K | ﹤0.01% | 1474 |
|
|
2016
Q2 | – | Sell |
-8,812
| Closed | -$255K | – | 1688 |
|
|
2016
Q1 | $255K | Buy |
8,812
+602
| +7% | +$15.7K | 0.01% | 1259 |
|
|
2015
Q4 | $247K | Sell |
8,210
-352
| -4% | -$12K | 0.01% | 1233 |
|
|
2015
Q3 | $255K | Sell |
8,562
-198
| -2% | -$6.44K | 0.01% | 1112 |
|
|
2015
Q2 | $307K | Sell |
8,760
-441
| -5% | -$15.6K | 0.01% | 1046 |
|
|
2015
Q1 | $326K | Sell |
9,201
-481
| -5% | -$16.2K | 0.01% | 1022 |
|
|
2014
Q4 | $335K | Sell |
9,682
-1,519
| -14% | -$53.6K | 0.01% | 964 |
|
|
2014
Q3 | $396K | Sell |
11,201
-273
| -2% | -$10.3K | 0.01% | 937 |
|
|
2014
Q2 | $461K | Sell |
11,474
-2,251
| -16% | -$86.4K | 0.02% | 794 |
|
|
2014
Q1 | $547K | Buy |
13,725
+4,899
| +56% | +$176K | 0.02% | 677 |
|
|
2013
Q4 | $291K | Sell |
8,826
-89
| -1% | -$2.77K | 0.01% | 901 |
|
|
2013
Q3 | $262K | Buy |
8,915
+1,696
| +23% | +$53.2K | 0.01% | 913 |
|
|
2013
Q2 | $243K | Buy |
+7,219
| New | +$223K | 0.01% | 852 |
|
Other funds holding DBD
BFIM
HNB
Cambridge Investment Research Advisors's DBD Position: Q2 2023 in Review
Cambridge Investment Research Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 10,875 shares — an estimated $13K sold.
Cambridge Investment Research Advisors first reported a position in DBD in Q2 2013 and held it in 29 quarters. The position peaked at $2.57M in Q1 2021. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.
- Cambridge Investment Research Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 10,875 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $13K.
- Cambridge Investment Research Advisors first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 29 quarters.
- Cambridge Investment Research Advisors's Diebold Nixdorf Incorporated position peaked at $2.57M in Q1 2021.
- 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.